Long-term outcomes after adjuvant treatment of sequential versus combination docetaxel with doxorubicin and cyclophosphamide in node-positive breast cancer: BCIRG-005 randomized trial

  • J. R. Mackey
  • , T. Pieńkowski
  • , J. Crown
  • , S. Sadeghi
  • , M. Martin
  • , A. Chan
  • , M. Saleh
  • , S. Sehdev
  • , L. Provencher
  • , V. Semiglazov
  • , M. F. Press
  • , G. Sauter
  • , M. Lindsay
  • , V. Houé
  • , M. Buyse
  • , P. Drevot
  • , S. Hitier
  • , S. Bensfia
  • , W. Eiermann

Research output: Contribution to journal › Article › peer-review

54 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Long-term outcomes after adjuvant treatment of sequential versus combination docetaxel with doxorubicin and cyclophosphamide in node-positive breast cancer: BCIRG-005 randomized trial'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology